Literature DB >> 23149719

Developmental changes in the responsiveness of rat spiral ganglion neurons to neurotrophic factors in dissociated culture: differential responses for survival, neuritogenesis and neuronal morphology.

Yulian Jin1, Kenji Kondo, Munetaka Ushio, Kimitaka Kaga, Allen F Ryan, Tatsuya Yamasoba.   

Abstract

The way that the development of the inner ear innervation is regulated by various neurotrophic factors and/or their combinations at different postnatal developmental stages remains largely unclear. Moreover, survival and neuritogenesis in deafferented adult neurons is important for cochlear implant function. To address these issues, developmental changes in the responsiveness of postnatal rat spiral ganglion neurons (SGNs) to neurotrophin-3 (NT-3), brain-derived neurotrophic factor (BDNF) and leukemia inhibitory factor (LIF) were examined by using a dissociated cell culture system. SGNs at postnatal day (P) 0, P5 and P20 (young adult) were cultured with the addition of NT-3, BDNF, or LIF or of a combination of NT-3 and BDNF (N + B) or of NT-3, BDNF and LIF (ALL factors). SGNs were analyzed for three parameters: survival, longest neurite length (LNL) and neuronal morphology. At P0, SGNs required exposure to N + B or ALL factors for enhanced survival and the ALL factors combination showed a synergistic effect much greater than the sum of the individual factors. At P5, SGNs responded to a wider range of treatment conditions for enhanced survival and combinations showed only an additive improvement over individual factors. The survival percentage of untreated SGNs was highest at P20 but combinations of neurotrophic factors were no more effective than individual factors. LNL of each SGN was enhanced by LIF alone or ALL factors at P0 and P5 but was suppressed by NT-3, BDNF and N + B at P5 in a dose-dependent manner. The LNL at P20 was enhanced by ALL factors and suppressed by N + B. Treatment with ALL factors increased the proportion of SGNs that had two or more primary neurites in all age groups. These findings suggest that NT-3, BDNF, LIF and their combinations predominantly support different ontogenetic events at different developmental stages in the innervation of the inner ear.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23149719      PMCID: PMC3577061          DOI: 10.1007/s00441-012-1526-1

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  65 in total

1.  Serum-free culture of dissociated, purified adult and aged sympathetic neurons and quantitative assays of growth and survival.

Authors:  N Orike; C Thrasivoulou; T Cowen
Journal:  J Neurosci Methods       Date:  2001-04-30       Impact factor: 2.390

2.  Differential regulation of survival and growth in adult sympathetic neurons: an in vitro study of neurotrophin responsiveness.

Authors:  N Orike; C Thrasivoulou; A Wrigley; T Cowen
Journal:  J Neurobiol       Date:  2001-06-15

Review 3.  Leukemia-inhibitory factor-neuroimmune modulator of endocrine function.

Authors:  C J Auernhammer; S Melmed
Journal:  Endocr Rev       Date:  2000-06       Impact factor: 19.871

4.  LIF is more potent than BDNF in promoting neurite outgrowth of mammalian auditory neurons in vitro.

Authors:  L N Gillespie; G M Clark; P F Bartlett; P L Marzella
Journal:  Neuroreport       Date:  2001-02-12       Impact factor: 1.837

5.  The neurotrophins act synergistically with LIF and members of the TGF-beta superfamily to promote the survival of spiral ganglia neurons in vitro.

Authors:  P L Marzella; L N Gillespie; G M Clark; P F Bartlett; T J Kilpatrick
Journal:  Hear Res       Date:  1999-12       Impact factor: 3.208

6.  Differential effects of NGF and NT-3 on embryonic trigeminal axon growth patterns.

Authors:  E Ulupinar; M F Jacquin; R S Erzurumlu
Journal:  J Comp Neurol       Date:  2000-09-18       Impact factor: 3.215

7.  Spatial shaping of cochlear innervation by temporally regulated neurotrophin expression.

Authors:  I Fariñas; K R Jones; L Tessarollo; A J Vigers; E Huang; M Kirstein; D C de Caprona; V Coppola; C Backus; L F Reichardt; B Fritzsch
Journal:  J Neurosci       Date:  2001-08-15       Impact factor: 6.167

8.  Development of primary axosomatic endings in the anteroventral cochlear nucleus of mice.

Authors:  C J Limb; D K Ryugo
Journal:  J Assoc Res Otolaryngol       Date:  2000-09

9.  IB4-binding DRG neurons switch from NGF to GDNF dependence in early postnatal life.

Authors:  D C Molliver; D E Wright; M L Leitner; A S Parsadanian; K Doster; D Wen; Q Yan; W D Snider
Journal:  Neuron       Date:  1997-10       Impact factor: 17.173

10.  Inhibition of apoptotic signaling cascades causes loss of trophic factor dependence during neuronal maturation.

Authors:  G V Putcha; M Deshmukh; E M Johnson
Journal:  J Cell Biol       Date:  2000-05-29       Impact factor: 10.539

View more
  11 in total

1.  Pleiotrophin increases neurite length and number of spiral ganglion neurons in vitro.

Authors:  Sebastian Bertram; Lars Roll; Jacqueline Reinhard; Katharina Groß; Stefan Dazert; Andreas Faissner; Stefan Volkenstein
Journal:  Exp Brain Res       Date:  2019-09-12       Impact factor: 1.972

2.  Neurotrophins differentially stimulate the growth of cochlear neurites on collagen surfaces and in gels.

Authors:  Joanna Xie; Kwang Pak; Amaretta Evans; Andy Kamgar-Parsi; Stephen Fausti; Lina Mullen; Allen Frederic Ryan
Journal:  Neural Regen Res       Date:  2013       Impact factor: 5.135

3.  Functional Pattern of Increasing Concentrations of Brain-Derived Neurotrophic Factor in Spiral Ganglion: Implications for Research on Cochlear Implants.

Authors:  Emina Ramku; Refik Ramku; Dugagjin Spanca; Valbona Zhjeqi
Journal:  Open Access Maced J Med Sci       Date:  2017-02-27

4.  Effect of hyperbaric oxygen on BDNF-release and neuroprotection: Investigations with human mesenchymal stem cells and genetically modified NIH3T3 fibroblasts as putative cell therapeutics.

Authors:  Jennifer Schulze; Odett Kaiser; Gerrit Paasche; Hans Lamm; Andreas Pich; Andrea Hoffmann; Thomas Lenarz; Athanasia Warnecke
Journal:  PLoS One       Date:  2017-05-23       Impact factor: 3.240

5.  Alginate-encapsulated brain-derived neurotrophic factor-overexpressing mesenchymal stem cells are a promising drug delivery system for protection of auditory neurons.

Authors:  Jana Schwieger; Anika Hamm; Michael M Gepp; André Schulz; Andrea Hoffmann; Thomas Lenarz; Verena Scheper
Journal:  J Tissue Eng       Date:  2020-04-17       Impact factor: 7.813

6.  Age-Dependency of Neurite Outgrowth in Postnatal Mouse Cochlear Spiral Ganglion Explants.

Authors:  Claudia Frick; Stefan Fink; Dominik Schmidbauer; Francis Rousset; Holger Eickhoff; Anke Tropitzsch; Benedikt Kramer; Pascal Senn; Rudolf Glueckert; Helge Rask-Andersen; Karl-Heinz Wiesmüller; Hubert Löwenheim; Marcus Müller
Journal:  Brain Sci       Date:  2020-08-21

7.  Neuronal Survival, Morphology and Outgrowth of Spiral Ganglion Neurons Using a Defined Growth Factor Combination.

Authors:  Jana Schwieger; Athanasia Warnecke; Thomas Lenarz; Karl-Heinz Esser; Verena Scheper
Journal:  PLoS One       Date:  2015-08-11       Impact factor: 3.240

8.  Polylactic-co-glycolic acid microspheres containing three neurotrophic factors promote sciatic nerve repair after injury.

Authors:  Qun Zhao; Zhi-Yue Li; Ze-Peng Zhang; Zhou-Yun Mo; Shi-Jie Chen; Si-Yu Xiang; Qing-Shan Zhang; Min Xue
Journal:  Neural Regen Res       Date:  2015-09       Impact factor: 5.135

9.  Advantageous environment of micro-patterned, high-density complementary metal-oxide-semiconductor electrode array for spiral ganglion neurons cultured in vitro.

Authors:  Viktorija Radotić; Dries Braeken; Petar Drviš; Marta Mattotti; Damir Kovačić
Journal:  Sci Rep       Date:  2018-05-10       Impact factor: 4.379

10.  BDNF, NT-3 and Trk receptor agonist monoclonal antibodies promote neuron survival, neurite extension, and synapse restoration in rat cochlea ex vivo models relevant for hidden hearing loss.

Authors:  Stephanie Szobota; Pranav D Mathur; Sairey Siegel; KristenAnn Black; H Uri Saragovi; Alan C Foster
Journal:  PLoS One       Date:  2019-10-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.